Wang XJ - Search Results

1

Mutation status of epidermal growth factor receptor and clinical features of patients with combined small cell lung cancer who received surgical treatment.

Lu HY, Mao WM, Cheng QY, Chen B, Cai JF, Wang XJ, Wang Z, Xie FJ. Lu HY, et al. Among authors: wang xj, wang z. Oncol Lett. 2012 Jun;3(6):1288-1292. doi: 10.3892/ol.2012.666. Epub 2012 Apr 2. Oncol Lett. 2012. PMID: 22783435 Free PMC article.

2

Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS.

Lei L, Wang XJ, Zheng ZG, Huang J, Cao WM, Chen ZH, Shao XY, Cai JF, Ye WW, Lu HY. Lei L, et al. Among authors: wang xj. Anat Rec (Hoboken). 2011 Jun;294(6):941-4. doi: 10.1002/ar.21399. Epub 2011 May 4. Anat Rec (Hoboken). 2011. PMID: 21548109 Free article.

3

Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer.

Lu HY, Zhang G, Cheng QY, Chen B, Cai JF, Wang XJ, Zhang YP, Wang Z, Lu ZY, Xie FJ, Mao WM. Lu HY, et al. Among authors: wang xj, wang z. Oncol Lett. 2012 Jul;4(1):89-93. doi: 10.3892/ol.2012.679. Epub 2012 Apr 12. Oncol Lett. 2012. PMID: 22807968 Free PMC article.

4

Targeted therapies in small cell lung cancer.

Lu HY, Wang XJ, Mao WM. Lu HY, et al. Among authors: wang xj. Oncol Lett. 2013 Jan;5(1):3-11. doi: 10.3892/ol.2012.791. Epub 2012 Jul 6. Oncol Lett. 2013. PMID: 23255884 Free PMC article.

5

Growth inhibitory effect of Cucurbitacin E on breast cancer cells.

Lan T, Wang L, Xu Q, Liu W, Jin H, Mao W, Wang X, Wang X. Lan T, et al. Int J Clin Exp Pathol. 2013 Aug 15;6(9):1799-805. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24040444 Free PMC article.

6

Identifying EGFR mutations from SCLC patient plasma by mutant-enriched liquidchip technology.

Lu HY, Lu ZY, Cheng QY, Cai JF, Wang XJ, Zhang YP, Lou CJ, Yu XM, Qin J, Ye WW, Lei L, Huang J, Yang HY, Mao WM. Lu HY, et al. Among authors: wang xj. Adv Clin Exp Med. 2014 Mar-Apr;23(2):191-5. doi: 10.17219/acem/37048. Adv Clin Exp Med. 2014. PMID: 24913109 Free article.

7

A meta-analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limited-disease small-cell lung cancer.

Lu H, Fang L, Wang X, Cai J, Mao W. Lu H, et al. Mol Clin Oncol. 2014 Sep;2(5):805-810. doi: 10.3892/mco.2014.311. Epub 2014 Jun 12. Mol Clin Oncol. 2014. PMID: 25054049 Free PMC article.

8

The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancer.

Shao X, Guo Y, Xu X, Zheng Y, Wang J, Chen Z, Huang J, Huang P, Cai J, Wang X. Shao X, et al. PLoS One. 2015 Mar 20;10(3):e0121535. doi: 10.1371/journal.pone.0121535. eCollection 2015. PLoS One. 2015. PMID: 25793413 Free PMC article.

9

Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer.

Meng X, Li Y, Tang H, Mao W, Yang H, Wang X, Ding X, Xie S. Meng X, et al. Amino Acids. 2016 Feb;48(2):487-97. doi: 10.1007/s00726-015-2102-2. Epub 2015 Oct 6. Amino Acids. 2016. PMID: 26439378

10

Expression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significance.

Chen Z, Xu S, Xu W, Huang J, Zhang GU, Lei L, Shao X, Wang X. Chen Z, et al. Oncol Lett. 2015 Aug;10(2):723-729. doi: 10.3892/ol.2015.3348. Epub 2015 Jun 10. Oncol Lett. 2015. PMID: 26622560 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,440 results

Search Page

Filters